课题基金 / 基金详情

Prostanoid Modulators that Reduce Brain Injury After Seizures

Prostanoid Modulators that Reduce Brain Injury After Seizures
前列腺素调节剂可减少癫痫发作后的脑损伤
批准号:
8144642
负责人:
RAYMOND J DINGLEDINE
金额:
$56.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2016-08-31

项目摘要

项目成果

RAYMOND J DINGLEDINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Current medical countermeasures to nerve gas exposure such as midazolam and atropine are of doubtful general utility for civilian populations because they must be administered within minutes of an attack to be effective. Therapies that can be administered hours after chemical exposure are needed. Prolonged status epilepticus (SE) induced by the muscarinic agonist, pilocarpine, or the organophosphate, diisopropyl fluorophosphate (DFP), triggers a similar series of cellular events in the brain that prominently includes substantial mortality and selective neuronal degeneration. We have evidence that activation of brain EP2 receptors can be neuroprotective after status epilepticus. Our overarching goal is to develop small molecules that act on specific prostanoid receptors to oppose seizure-induced neurodegeneration. We have recently created the first allosteric potentiators of the EP2 receptor for PGE2 and have shown they are neuroprotective in vitro. The objective of the next project period is to develop these compounds into a practical nerve gas countermeasure. Achieving the objective of developing a novel countermeasure that can be administered hours after exposure to nerve gases will require: a) compelling proof-of-principle studies for EP2-mediated neuroprotection in the pilocarpine and DFP models of brain damage; b) optimizing EP2 allosteric potentiators for brain pharmacokinetics and potency, testing them against pilocarpine, DFP and sarin; c) completing FDA-mandated preclinical safety pharmacology and submitting an IND for use as a countermeasure for nerve gas attack or accidental release. Work will be organized around annual milestones. Public Health Relevance: Injury of the brain is a major target of nerve gases, and is often associated with long-term disability with unusually high accompanying social and medical costs. We intend to create novel drugs that target inflammation pathways to minimize the brain damage and cognitive deficits that accompany prolonged seizures..
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10467539
  • 项目类别:
  • 资助金额:
    $67.75万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10732636
  • 项目类别:
  • 资助金额:
    $67.95万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10356163
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10171930
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
海外基金